244 related articles for article (PubMed ID: 9101366)
1. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors.
Siwek B; Lacroix M; De Pollak C; Marie P; Body JJ
J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells.
Fromigué O; Kheddoumi N; Lomri A; Marie PJ; Body JJ
J Bone Miner Res; 2001 Sep; 16(9):1600-10. PubMed ID: 11547830
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
7. Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment.
Brama M; Basciani S; Cherubini S; Mariani S; Migliaccio S; Arizzi M; Rosano G; Spera G; Gnessi L
Endocr Relat Cancer; 2007 Mar; 14(1):61-72. PubMed ID: 17395975
[TBL] [Abstract][Full Text] [Related]
8. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
10. Effects of secretory products of breast cancer cells on osteoblast-like cells.
Lacroix M; Siwek B; Body JJ
Breast Cancer Res Treat; 1996; 38(2):209-16. PubMed ID: 8861839
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation.
Mastro AM; Gay CV; Welch DR; Donahue HJ; Jewell J; Mercer R; DiGirolamo D; Chislock EM; Guttridge K
J Cell Biochem; 2004 Feb; 91(2):265-76. PubMed ID: 14743387
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells.
Bunyaratavej P; Hullinger TG; Somerman MJ
Exp Cell Res; 2000 Nov; 260(2):324-33. PubMed ID: 11035927
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF
Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945
[TBL] [Abstract][Full Text] [Related]
14. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line.
Johnston PG; Rondinone CM; Voeller D; Allegra CJ
Cancer Res; 1992 Dec; 52(24):6860-5. PubMed ID: 1458474
[TBL] [Abstract][Full Text] [Related]
15. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
[TBL] [Abstract][Full Text] [Related]
16. Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells.
Dean DD; Schwartz Z; Blanchard CR; Liu Y; Agrawal CM; Lohmann CH; Sylvia VL; Boyan BD
J Orthop Res; 1999 Jan; 17(1):9-17. PubMed ID: 10073642
[TBL] [Abstract][Full Text] [Related]
17. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells.
Dembinski TC; Leung CK; Shiu RP
Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846
[TBL] [Abstract][Full Text] [Related]
19. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.
van der Burg B; Isbrücker L; van Selm-Miltenburg AJ; de Laat SW; van Zoelen EJ
Cancer Res; 1990 Dec; 50(24):7770-4. PubMed ID: 2174732
[TBL] [Abstract][Full Text] [Related]
20. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
